Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 4, 2013, Pages 1961-1964

  Hong, Eva ^a   Thulin Hedberg, Sara ^b   Abad, Raquel ^c   Fazio, Cecilia ^d   Enríquez, Rocío ^c   Deghmane, Ala Eddine ^a   Jolley, Keith A ^e   Stefanelli, Paola ^d   Unemo, Magnus ^b   Vazquez, Julio A ^c   Veyrier, Frédéric J ^a   Taha, Muhamed Kheir ^a  

^a INSTITUT PASTEUR   (France)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CLEARANCE; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE SEQUENCE; GENE TARGETING; MENINGOCOCCOSIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NEISSERIA CINEREA; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DNA GYRASE; FEMALE; MENINGOCOCCAL INFECTIONS; MICE; MICE, TRANSGENIC; MICROBIAL SENSITIVITY TESTS; NEISSERIA MENINGITIDIS;

EID: 84875198033     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02184-12     Document Type: Article

References (16)

1. Zalmanovici Trestioreanu A, Fraser A, Gafter-Gvili A, Paul M, Leibovici L. 2011. Antibiotics for preventing meningococcal infections. Cochrane Database Syst. Rev. 10:CD004785. doi: 10.1002/14651858.CD004785.pub4.
2. Enríquez R, Abad R, Salcedo C, Perez S, Vazquez JA. 2008. Fluoroquinolone resistance in Neisseria meningitidis in Spain. J. Antimicrob. Chemother. 61:286 -290.
3. Taha MK, Vazquez JA, Hong E, Bennett DE, Bertrand S, Bukovski S, Cafferkey MT, Carion F, Christensen JJ, Diggle M, Edwards G, Enríquez R, Fazio C, Frosch M, Heuberger S, Hoffmann S, Jolley KA, Kadlubowski M, Kechrid A, Kesanopoulos K, Kriz P, Lambertsen L, Levenet I, Musilek M, Paragi M, Saguer A, Skoczynska A, Stefanelli P, Thulin S, Tzanakaki G, Unemo M, Vogel U, Zarantonelli ML. 2007. Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis. Antimicrob. Agents Chemother. 51:2784 -2792.
4. Tettelin H, Saunders NJ, Heidelberg J, Jeffries AC, Nelson KE, Eisen JA, Ketchum KA, Hood DW, Peden JF, Dodson RJ, Nelson WC, Gwinn ML, DeBoy R, Peterson JD, Hickey EK, Haft DH, Salzberg SL, White O, Fleischmann RD, Dougherty BA, Mason T, Ciecko A, Parksey DS, Blair E, Cittone H, Clark EB, Cotton MD, Utterback TR, Khouri H, Qin H, Vamathevan J, Gill J, Scarlato V, Masignani V, Pizza M, Grandi G, Sun L, Smith HO, Fraser CM, Moxon ER, Rappuoli R, Venter JC. 2000. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287:1809 -1815.
5. Smith JM. 1992. Analyzing the mosaic structure of genes. J. Mol. Evol. 34:126 -129.
6. Jolley KA, Feil EJ, Chan MS, Maiden MC. 2001. Sequence type analysis and recombinational tests (START). Bioinformatics 17:1230 -1231.
7. Skoczynska A, Alonso JM, Taha MK. 2008. Ciprofloxacin resistance in Neisseria meningitidis, France. Emerg. Infect. Dis. 14:1322-1323.
8. Taha MK, Morand PC, Pereira Y, Eugene E, Giorgini D, Larribe M, Nassif X. 1998. Pilus-mediated adhesion of Neisseria meningitidis: the essential role of cell contact-dependent transcriptional upregulation of the PilC1 protein. Mol. Microbiol. 28:1153-1163.
9. Zarantonelli ML, Szatanik M, Giorgini D, Hong E, Huerre M, Guillou F, Alonso JM, Taha MK. 2007. Transgenic mice expressing human transferrin as a model for meningococcal infection. Infect. Immun. 75:5609-5614.
10. Szatanik M, Hong E, Ruckly C, Ledroit M, Giorgini D, Jopek K, Nicola MA, Deghmane AE, Taha MK. 2011. Experimental meningococcal sepsis in congenic transgenic mice expressing human transferrin. PLoS One 6:e22210. doi: 10.1371/journal.pone.0022210.
11. Saini SP, Srivastava AK. 2001. The disposition kinetics, urinary excretion and dosage regimen of ciprofloxacin in buffalo calves (Bubalus bubalis). Vet. Res. Commun. 25:641- 649.
12. Corso A, Faccone D, Miranda M, Rodriguez M, Regueira M, Carranza C, Vencina C, Vazquez JA, Galas M. 2005. Emergence of Neisseria meningitidis with decreased susceptibility to ciprofloxacin in Argentina. J. Antimicrob. Chemother. 55:596 -597.
13. Singhal S, Purnapatre KP, Kalia V, Dube S, Nair D, Deb M, Aggarwal P, Gupta S, Upadhyay DJ, Rattan A, Raj VS. 2007. Ciprofloxacinresistant Neisseria meningitidis, Delhi, India. Emerg. Infect. Dis. 13:1614-1616.
14. Wu HM, Harcourt BH, Hatcher CP, Wei SC, Novak RT, Wang X, Juni BA, Glennen A, Boxrud DJ, Rainbow J, Schmink S, Mair RD, Theodore MJ, Sander MA, Miller TK, Kruger K, Cohn AC, Clark TA, Messonnier NE, Mayer LW, Lynfield R. 2009. Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America. N. Engl. J. Med. 360:886-892.
15. Strahilevitz J, Adler A, Smollan G, Temper V, Keller N, Block C. 2008. Serogroup A Neisseria meningitidis with reduced susceptibility to ciprofloxacin. Emerg. Infect. Dis. 14:1667-1669.
16. Lindbäck E, Rahman M, Jalal S, Wretlind B. 2002. Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae. APMIS 110:651- 657.